OBM Genetics is an international Open Access journal published quarterly online by LIDSEN Publishing Inc. It accepts papers addressing basic and medical aspects of genetics and epigenetics and also ethical, legal and social issues. Coverage includes clinical, developmental, diagnostic, evolutionary, genomic, mitochondrial, molecular, oncological, population and reproductive aspects. It publishes a variety of article types (Original Research, Review, Communication, Opinion, Comment, Conference Report, Technical Note, Book Review, etc.). There is no restriction on the length of the papers and we encourage scientists to publish their results in as much detail as possible.

Publication Speed (median values for papers published in 2023): Submission to First Decision: 5.1 weeks; Submission to Acceptance: 17.0 weeks; Acceptance to Publication: 7 days (1-2 days of FREE language polishing included)

Current Issue: 2024  Archive: 2023 2022 2021 2020 2019 2018 2017

Special Issue

Pharmacogenomics and Precision Medicine: Unraveling the Future of Personalized Therapy

Submission Deadline: October 31, 2024 (Open) Submit Now

Guest Editor

Ahmad R. Alsayed, PhD, Associate Professor

Therapeutics and Precision Medicine, Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan

Website | E-Mail

Research Interests: microbiome dysbiosis; microbiome health; pharmacogenomics; drug development

About This Topic

Pharmacogenomics, the study of how an individual's genetic makeup influences their response to drugs, is at the forefront of modern medicine's transition towards precision and personalized therapies. Recent advancements in genomic technologies and innovative computational approaches have enabled us to unravel the complex interplay between genetic variations, drug metabolism, and treatment outcomes. This special issue aims to showcase the latest breakthroughs in pharmacogenomics research, emphasizing its pivotal role in shaping the landscape of precision medicine.

We invite researchers and clinicians to contribute their original research, reviews, and perspectives on various dimensions of pharmacogenomics and its applications in precision medicine. Topics of interest include, but are not limited to:

  1. Genomic Variation and Drug Response: Explore the influence of genetic polymorphisms on drug metabolism, efficacy, safety, and adverse reactions across different therapeutic areas. 
  2. Pharmacogenomics in Oncology: Highlight the role of pharmacogenomics in tailoring cancer treatments, optimizing chemotherapy regimens, and predicting drug responses in cancer patients. 
  3. Translational Applications: Discuss the implementation of pharmacogenomics findings in clinical practice, focusing on strategies to bridge the gap between research and real-world patient care. 
  4. Bioinformatics and Data Integration: Present novel bioinformatics tools and integrative approaches for analyzing large-scale genomic and clinical datasets in the context of pharmacogenomics. 
  5. Ethical and Regulatory Considerations: Examine the ethical, legal, and regulatory challenges of integrating pharmacogenomics into clinical decision-making and patient care. 
  6. Pharmacogenomics and Drug Development: Explore how pharmacogenomics influences drug discovery, clinical trial design, and the development of targeted therapies. 
  7. Patient Education and Engagement: Discuss approaches to effectively communicate pharmacogenomics information to patients, empowering them to make informed decisions about their treatment plans. 

Manuscript Submission Information

Manuscripts should be submitted through the LIDSEN Submission System. Detailed information on manuscript preparation and submission is available in the Instructions for Authors. All submitted articles will be thoroughly refereed through a single-blind peer-review process and will be processed following the Editorial Process and Quality Control policy. Upon acceptance, the article will be immediately published in a regular issue of the journal and will be listed together on the special issue website, with a label that the article belongs to the Special Issue. LIDSEN distributes articles under the Creative Commons Attribution (CC BY 4.0) License in an open-access model. The authors own the copyright to the article, and the article can be free to access, distribute, and reuse provided that the original work is correctly cited.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). Research articles and review articles are highly invited. Authors are encouraged to send the tentative title and abstract of the planned paper to the Editorial Office (genetics@lidsen.com) for record. If you have any questions, please do not hesitate to contact the Editorial Office.

Welcome your submission!